T1695
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T1695, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis [Phase 2]